Lipid-rich ascites reprograms the T cell lipid metabolic transcriptome to drive dysfunction

Abstract Malignant ascites is a lipid-rich, immunosuppressive environment that has recently emerged as a target for locoregional bispecific T-cell engager (BiTE) therapy. However, the mechanisms by which ascites, particularly its lipid components, suppress antitumour immunity and limit therapeutic efficacy remain poorly understood. Here, we investigated the impact of ascites lipids on T-cell immunosuppression and assessed whether lipid modulation could enhance the efficacy of BiTE therapy. Transcriptomic profiling of T cells exposed to acellular ascites fluid revealed an enriched signature associated with cholesterol efflux and incomplete fatty acid oxidation, which are metabolic features often found in exhausted T cells. These alterations converged on a metabolically imbalanced state linked to impaired plasma membrane signalling. Meanwhile, anti-CD3/CD28-stimulated T cells showed marked lipid accumulation in ascites, which was attenuated by lipid depletion. Functionally, lipid removal was associated with enhanced TCR-associated signalling, as demonstrated by increased ZAP70 phosphorylation, and restored CD137 expression while leaving CD25 unchanged. To determine whether ascites lipids also affected BiTE efficacy, T cells were cocultured with ovarian cancer cells and an EpCAM-targeting BiTE in untreated or lipid-depleted ascites. Ascites suppressed BiTE-mediated T-cell activation and abolished tumour cell killing, whereas lipid depletion contributed to the restoration of T-cell activation, IFN-γ production and BiTE-mediated cytotoxicity. Together, these findings suggest that lipids contribute to T-cell dysfunction in ovarian cancer ascites and demonstrate that lipid depletion is associated with restored antitumour T-cell activity. Targeting this metabolic barrier may therefore provide a combination strategy to potentiate BiTE therapy in malignant ascites.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Research
Published
2026-11-13
DOI
https://doi.org/10.1158/2326-6066.cir-26-0206
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lipid-rich ascites reprograms the T cell lipid metabolic transcriptome to drive dysfunction

Kerry D. Fisher, Leonard William Seymour, Gülşah Albayrak, Peter Kok-Ting Wan et al.
2 links
Cancer Immunology Research
Cancer Immunotherapy and Biomarkers
article

Lipid-rich ascites reprograms the T cell lipid metabolic transcriptome to drive dysfunction

Kerry D. Fisher, Leonard William Seymour, Gülşah Albayrak, Peter Kok-Ting Wan, Puck E Bruchner, Luke Furtado. O’Mahony, Shuangye Yan
article en

Abstract

Abstract Malignant ascites is a lipid-rich, immunosuppressive environment that has recently emerged as a target for locoregional bispecific T-cell engager (BiTE) therapy. However, the mechanisms by which ascites, particularly its lipid components, suppress antitumour immunity and limit therapeutic efficacy remain poorly understood. Here, we investigated the impact of ascites lipids on T-cell immunosuppression and assessed whether lipid modulation could enhance the efficacy of BiTE therapy. Transcriptomic profiling of T cells exposed to acellular ascites fluid revealed an enriched signature associated with cholesterol efflux and incomplete fatty acid oxidation, which are metabolic features often found in exhausted T cells. These alterations converged on a metabolically imbalanced state linked to impaired plasma membrane signalling. Meanwhile, anti-CD3/CD28-stimulated T cells showed marked lipid accumulation in ascites, which was attenuated by lipid depletion. Functionally, lipid removal was associated with enhanced TCR-associated signalling, as demonstrated by increased ZAP70 phosphorylation, and restored CD137 expression while leaving CD25 unchanged. To determine whether ascites lipids also affected BiTE efficacy, T cells were cocultured with ovarian cancer cells and an EpCAM-targeting BiTE in untreated or lipid-depleted ascites. Ascites suppressed BiTE-mediated T-cell activation and abolished tumour cell killing, whereas lipid depletion contributed to the restoration of T-cell activation, IFN-γ production and BiTE-mediated cytotoxicity. Together, these findings suggest that lipids contribute to T-cell dysfunction in ovarian cancer ascites and demonstrate that lipid depletion is associated with restored antitumour T-cell activity. Targeting this metabolic barrier may therefore provide a combination strategy to potentiate BiTE therapy in malignant ascites.

Cancer Immunology Research
University of Oxford (GB), Science Oxford (GB)
Cancer Research UK
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon